MU surged +8.63% during regular market hours, climbing from yesterday's close of $948.80 to $1,030.72, reversing a sharp multi-day selloff that had pushed the stock into bear-market territory. The primary catalyst was a powerful memory-sector rebound triggered by Samsung's blowout preliminary Q2 results showing a 19-fold year-over-year profit surge, which reaffirmed that AI-driven memory demand remains robust.
Lam Research shares surged +9.94% during regular market hours on Thursday, rebounding sharply from the prior session's close of $333.15 to trade near $366.26, as the entire semiconductor sector staged a powerful recovery. The primary catalyst was a broad chip-stock rally fueled by reports that China may ease restrictions on advanced AI chip imports, potentially expanding demand for high-end semiconductor equipment.
BSP fell -5.35% during regular trading on July 9, sliding to $32.40 and extending its post-IPO decline for a seventh consecutive session below the $40.50 first-day close. The stock now sits just +11.7% above its $29 IPO price, as profit-taking continues to unwind the initial +39.7% debut surge from July 1.
AVAV is trading at $149.72 during regular market hours, down -5.11% from yesterday's close of $157.78, extending a multi-week selloff that has pushed the stock down roughly -38% year to date. The decline follows a failed bounce from the company's July 8 Investor Day, where ambitious FY2030 targets of $3.5–$4.0 billion in revenue and 18%–20% adjusted EBITDA margins initially lifted shares +7% before gains fully reversed into the close.
PSKY dropped -8.12% during Thursday's regular session, sliding from a $9.75 prior close to roughly $8.96 intraday. The decline followed a Reuters report that a coalition of U.S. states led by California is preparing to sue to block the $110B Paramount–Warner Bros. Discovery merger as soon as next week.
Noah Holdings shares are trading roughly 13% lower in premarket action on Thursday, largely reflecting the stock going ex-dividend rather than a fundamental deterioration in the business. The primary driver is the combined final and special dividend of USD 0.69032 per ADS each (approximately USD 1.38 total), with July 9, 2026 marking both the ex-dividend and record date.
Both IREN and WULF operate renewable-powered data centers transitioning from Bitcoin mining toward AI and high-performance computing (HPC) infrastructure. WULF has delivered stronger year-to-date momentum, with gains exceeding 50% in recent market activity driven by major AI leasing announcements.
Explosive growth in artificial intelligence infrastructure spending by major technology companies is expected to sustain strong demand for advanced semiconductors. Continued capital expenditures in data centers and high-performance computing represent a key long-term driver for the underlying index.
Opus Genetics (IRD) shares traded near $4.10 in early July 2026, reflecting a modest 30-day gain of approximately 1.7% from the $4.03 close on June 8, 2026. The stock has pulled back roughly 26% over the past quarter from mid-April levels above $5.50, despite a year-to-date gain exceeding 100%.
Ionis Pharmaceuticals shares are plunging roughly 20.65% in premarket trading, falling from a previous close of $84.46 to around $67.02. The primary catalyst is the failure of the Phase 3 CARDIO-TTRansform trial for eplontersen, co-developed with AstraZeneca, which missed its primary efficacy endpoint in patients with transthyretin-mediated amyloid cardiomyopathy.
SOXL declined approximately 17% over the past 30 days, as a sharp semiconductor sector selloff was amplified by the fund's 3X daily leveraged structure. The ETF had surged to a peak near 301 in late June before geopolitical tensions and trade policy uncertainty triggered an aggressive reversal.
Fox Corporation (FOX) and Fox Corporation (FOXA) represent dual share classes of the same media company, with FOXA (Class A, voting) typically trading at a premium to FOX (Class B, non-voting) due to governance differences. Both stocks have delivered strong year-to-date returns exceeding 25% through early July 2026, outperforming the S&P 500, though they have retreated from January 2026 highs amid broader media sector volatility.
ASML Holding has delivered significantly stronger year-to-date performance than NVIDIA amid robust demand for semiconductor manufacturing equipment. Both companies benefit from artificial intelligence-driven growth, with ASML supplying critical lithography systems and NVIDIA providing graphics processing units and data center solutions.
Both STX and WDC have delivered exceptional year-to-date gains exceeding 200% amid surging demand for data storage solutions tied to artificial intelligence infrastructure. Seagate Technology focuses primarily on hard disk drives (HDDs) for nearline cloud and enterprise applications, while Western Digital maintains a diversified presence across HDDs and NAND flash memory through its joint venture.
Both GOOG and GOOGL represent ownership in Alphabet Inc., with GOOGL carrying voting rights and GOOG offering slightly higher liquidity in some sessions. Recent market activity shows both stocks trading within a broad range amid AI sector momentum and regulatory developments in Europe and India.
VXX is an exchange-traded note (ETN) that provides exposure to short-term S&P 500 VIX futures, making it a volatility-focused vehicle rather than a traditional equity or thematic fund. XXX is a strategy ETF designed to replicate a 75/25 blend of S&P 500 equity returns and S&P XRP futures performance, offering combined equity and cryptocurrency futures exposure.
Advanced Micro Devices (AMD) has delivered significantly stronger year-to-date returns than NVIDIA (NVDA), with gains exceeding 130% compared to NVDA’s approximately 9-13% advance amid broader semiconductor sector rotation. Both companies reported robust first-quarter 2026 results, with AMD revenue reaching $10.3 billion (up 38% year-over-year) and NVDA maintaining dominant positioning in artificial intelligence (AI) accelerators with an estimated 70-80% market share.
Corcept Therapeutics (CORT) operates in the biopharmaceutical sector with a focus on cortisol modulation therapies, while Chesapeake Utilities Corporation (CPK) provides regulated natural gas and energy delivery services across multiple U.S. states. Recent market activity shows CORT exhibiting higher volatility tied to clinical and commercial developments, whereas CPK has demonstrated more stable price behavior consistent with defensive utility characteristics.
Corcept Therapeutics (CORT) has delivered substantially stronger year-to-date returns compared with OPKO Health (OPK), driven by positive clinical data presentations and proximity to 52-week highs. Both companies operate in the healthcare sector but differ markedly in scale, with CORT holding a market capitalization near $10 billion versus OPK’s approximately $1.15 billion.
Maximus, Inc. (MMS) operates in government services with recent earnings momentum and a share repurchase authorization supporting capital returns. TowneBank (TOWN) focuses on regional banking in Virginia and North Carolina, emphasizing community lending and wealth management amid stable but modest performance.